Transient Severe Liver Injury: A Unique Presentation of COVID-19 Disease in a Pediatric Patient

Vasiliki Sgouropoulou1, Euthymia Vargiami, Maria Kyriazi

  • 1From the First Department of Pediatrics, Aristotle University Thessaloniki, Hippokration Hospital, Thessaloniki, Greece.

Insights

Coronavirus disease 2019 (COVID-19) can cause severe liver injury, even in children with mild symptoms. Prompt recognition of hepatic damage is crucial for effective management in pediatric patients.

Area of Science:

  • Hepatology
  • Virology
  • Pediatric Medicine

Background:

  • Hepatotoxicity is a recognized complication of coronavirus disease 2019 (COVID-19).
  • The spectrum of liver injury in COVID-19 can range from mild transaminitis to severe hepatic dysfunction.
  • Pediatric involvement in COVID-19 has been associated with various clinical manifestations, including liver injury.

Observation:

  • A pediatric case of COVID-19 with a mild clinical phenotype is presented.
  • This patient experienced transient but severe liver injury.
  • The hepatic damage occurred despite the overall mild presentation of the disease.

Findings:

  • Transient severe liver injury can occur in pediatric patients with COVID-19.
  • Liver dysfunction may be present even in mild cases of coronavirus disease 2019.
  • The severity of hepatic damage is not always correlated with the overall clinical severity of COVID-19 in children.

Implications:

  • Healthcare providers should consider hepatic damage in the differential diagnosis of children with COVID-19, irrespective of symptom severity.
  • Early identification and management of COVID-19-related liver injury are essential for improved patient outcomes.
  • Further research is warranted to understand the mechanisms of COVID-19-induced hepatotoxicity in pediatric populations.

Related Concept Videos

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
424
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
278
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
540
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
243
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
76
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.6K